Reaction
Carcinoid Tumour Pulmonary reporting signals
As of the last recalculation, Carcinoid Tumour Pulmonary appears in 239 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is EVEROLIMUS TABLETS (PRR 151.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Everolimus Tablets | 26 | 151.4 | 151.6 |
| Lanreotide Acetate | 12 | 140.3 | 140.5 |
| Telmisartan | 21 | 112.2 | 112.4 |
| Goserelin | 13 | 89.1 | 89.2 |
| Everolimus | 33 | 65.4 | 65.4 |
| Pseudoephedrine Hcl | 3 | 24.0 | 24.0 |